Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical prostatectomy

Urology

Volumn 47, Issue 2, 1996, Pages 232-235

  Coetzee, Lance J ^a   Hars, Veronika ^a   Paulson, David F ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; TREATMENT OUTCOME;

EID: 0029864777     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)80422-1     Document Type: Article

References (16)

1. McCarthy JF, Catalona WJ, and Hudson MA: Effect of radiation therapy on detectable serum PSA levels following radical prostatectomy: early versus delayed treatment. J Urol 151: 1575-1578, 1994.
2. Catalona WJ, and Stein AJ: Staging errors in clinically localized prostatic cancer. J Urol 127: 452-456, 1982.
3. Gibbons RP, Cole BS, Richardson RG, Correa RJ Jr, Brannen GE, Mason T, Taylor WJ, and Hafermann MD: Adjuvant radiotherapy following radical prostatectomy: results and complications. J Urol 135: 65-68, 1986.
4. 1 prostate cancer following radical prostatectomy. J Urol 142: 1266-1270, 1989.
5. Hudson MA, and Catalona WJ: Effect of adjuvant radiation therapy on prostate specific antigen following radical prostatectomy. J Urol 143: 1174-1177, 1990.
6. Walsh PC: Adjuvant radiotherapy after radical prostatectomy: is it indicated? J Urol 138: 1427-1428, 1987.
7. Anscher MS, and Prosnitz LR: Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule. J Urol 138: 1407-1412, 1987.
8. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, and Redwine E: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 317: 909-916, 1987.
9. Lange PH, Ercole CJ, Lightner DJ, Fraley EE, and Vessella R: The value of serum prostate specific antigen determinations before and after radical prostatectomy. J Urol 141: 873-879, 1989.
10. Freeman JA, Lieskovsky GA, Cook DW, Petrovich Z, Chen SC, Groshen S, and Skinner DG: Radical retropubic prostatectomy and postoperative adjuvant radiation for pathological stage C (PCN0) prostate cancer from 1976 to 1989: intermediate findings. J Urol 149: 1029-1034, 1993.
11. Hudson MA, Bahnson RB, and Catalona WJ: Clinical use of prostate specific antigen in patients with prostate cancer. J Urol 142: 1011-1017, 1989 .
12. Oesterling JE, Chan DW, Epstein JI, Kimball AW, Jr, Bruzek DJ, Rock RC, Brendler CB, and Walsh PC: Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 139: 766-772, 1988.
13. Lightner DJ, Reddy PK, and Lange PH: PSA response to radiation therapy(RT) after radical prostatectomy (RP): correlation with biopsy (Bx) and rectal exam (abstract 55). J Urol 141 (pt 2): 183A, 1989.
14. 1 prostate cancer. Cancer Res 45: 886-891, 1985.
15. Link P, Freiha FS, and Stamey TA: Adjuvant radiation therapy in patients with detectable prostate specific antigen following radical prostatectomy. J Urol 145: 532-534, 1991.
16. Lange PH, Lightner DJ, Medini E, Reddy PK, and Vessela RL: The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels. J Urol 144: 927-932, 1990.